课题基金 / 基金详情

Implementation of a clinical population screening program for BRCA1/2 mutations among individuals of Ashkenazi Jewish ancestry

Implementation of a clinical population screening program for BRCA1/2 mutations among individuals of Ashkenazi Jewish ancestry
在德系犹太血统个体中实施 BRCA1/2 突变临床人群筛查计划
批准号：
484636
负责人：
Shickh Salma A
金额：
$3.95万
依托单位：
BC Cancer, part of PHSA (Vancouver)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-03-01 至 2025-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=484636&lang=en
关键词：
Cancer Prevention Genetic Diseases Health Policy Health Systems Hereditary Cancer Syndromes Knowledge Translation Learning Health System Population Screening Public Health

项目摘要

项目成果

Shickh Salma A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Approximately 1 in 40 individuals who have Ashkenazi Jewish ancestry are born with a mutation in the BRCA1 or BRCA2 gene, in comparison to 1 in 300 in the general population. These individuals are at a high risk to develop multiple cancers over their life
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cancer patients' preferences for incidental genomic sequencing results
  • 批准号：
    412208
  • 项目类别：
  • 资助金额：
    $0.11万
  • 财政年份：
    2019
  • 负责人：
    Shickh Salma A
  • 依托单位：
    Unity Health Toronto
The Clinical Utility of Genomic Sequencing in Hereditary Cancer Syndrome Care: A Prospective, Mixed-Methods Cohort Study
  • 批准号：
    408182
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $7.65万
  • 财政年份：
    2018
  • 负责人：
    Shickh Salma A
  • 依托单位：
    Unity Health Toronto
海外基金